Browse 66 market data Tables and 72 Figures spread through 158 Pages and in-depth TOC on “3D Cell Culture Market by Technology (Scaffold Based, Scaffold Free) by Application (Cancer Research, Stem Cell Technology, Primary Cell Research, Tissue Engineering & Regenerative Medicines, Human Cell Lines, Tumor Xenografting, Drug Discovery, and Others) by End-Users (Research Laboratories, Biotechnology and Pharmaceuticals Industries, Hospitals and Diagnostics Centers and Others) – Global Forecast to 2021”
Early buyers will receive 10% customization on reports.
The global 3D cell culture market size is expected to reach USD 1345.2 Million by 2021, at a CAGR of 23.6% during the forecast period of 2016 to 2021.
The global 3D cell culture market is steadily progressing owing to various factors, such as increasing research in 3D cell culture, investments done by pharmaceutical and biotechnology companies in 3D cell culture, initiatives undertaken by governments for implementing research in 3D cell culture, and rapid increase in the need for organ transplantation.
3D cell culture is one of the new evolving field of research and technology in the market. It provides a 3D environment to the cells to grow in all directions, providing more accurate results than 2D procedures.
North America accounted for the largest share of the global 3D cell culture market, and was dominated largely by the U.S. Increasing number of organ transplantation and increasing demand of research especially in cancer is driving the U.S. market. Europe is the second-largest market for 3D cell culture with Germany leading the market in the region. The limitations of the global 3D cell culture market are huge investments required in 3D cell culture and lack of professionals in this field.
Major companies operational in the 3D Cell Culture market are:
3D Biotek LLC (U.S.), Becton, Dickinson and Company (U.S.), Corning Incorporated (U.S.), Thermo Fisher Scientific (U.S.), Global Cell Solutions, Inc. (U.S.), Kuraray Co. Ltd. (Japan), Lonza Group (Switzerland), Merck & Co., Inc. (U.S.), Sigma Aldrich Corporation (U.S.), Reinnervate Ltd, (a subsidiary of ReproCELL) (U.K.), and others.
The research study is aimed at identifying emerging trends and opportunities in the global 3D cell culture market along with detailed classifications, in terms of revenue. It provides a comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global 3D cell culture market on the basis of technology type, application type, end-user, and geography.
Request Free Sample Pages! http://www.marketsandmarkets.com/requestsample.asp?id=191072847
Apart from the market segmentation, this report also provides an in-depth analysis of the market by providing a detailed process flow diagram and market dynamics, such as drivers, restraints, and opportunities in the global 3D cell culture market.